Partners - Modelis

Bring success to new drug discovery projects

We partner with Pharmaceutical Companies, Patient Organizations, Academic Institutions, and more.

We support organizations looking to rapidly deepen their understanding of rare disease pathologies with the goal of producing personalized-medicine solutions. For example, we recently leveraged one of our partner’s proprietary library of compounds, and discovered a novel insight that will help advance understandings around an uncured, rare genetic disease.

We have a drug discovery process that can be used for any potential genetic disease.

Custom disease models can be generated to fit partners’ needs, and custom-designed R&D programs can be created to support existing activities or launch new discovery programs.

PHARMACEUTICAL COMPANIES

Pharmaceutical Companies know that drug discovery is expensive, especially when Research and Development initiatives aren’t successful. Modelis’ enables your organization to rapidly repurpose existing or failed treatments to enhance your organizations offerings. We help your company expand into the rare disease space.

Repurpose

Do you have unused proprietary compounds? We will repurpose them for you.

Low Risk

The Modelis approach minimizes risk while maximizing the chances of human applications.

Fast

Our research methodology enables you to realize outcomes quickly.

VENTURE PHILANTHROPISTS

Modelis develops personalized drug discovery projects to identify new therapies for rare diseases. We work with families, and Patient Advocacy Groups (PAG’s) to positively impact the genetic diseases they care about most. We share in the upside so that both of our organizations can improve the lives of patients with genetic diseases. We bridge the gap between bench and bedside to improve patient care, and patient outcomes.

Transparency

Our partners are part of each step of the drug discovery process.

Insight

Venture Philanthropists become meaningful contributors to finding a cure.

Fast

Our research methodology enables you to realize outcomes quickly.

GENETIC SEQUENCING GROUPS

Modelis provides functional genetic testing services to quickly validate genetic variants. This provides more definite data to our patients while providing an early contact with venture philanthropists for new drug discovery projects.